0001017491-17-000015.txt : 20170106
0001017491-17-000015.hdr.sgml : 20170106
20170106193033
ACCESSION NUMBER: 0001017491-17-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170105
FILED AS OF DATE: 20170106
DATE AS OF CHANGE: 20170106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APRICUS BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001017491
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870449967
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11975 EL CAMINO REAL,
STREET 2: SUITE 300
CITY: SAN DIEGO,
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 222-8041
MAIL ADDRESS:
STREET 1: 11975 EL CAMINO REAL,
STREET 2: SUITE 300
CITY: SAN DIEGO,
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: NEXMED INC
DATE OF NAME CHANGE: 19970311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morton Neil
CENTRAL INDEX KEY: 0001670896
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22245
FILM NUMBER: 17515543
MAIL ADDRESS:
STREET 1: C/O APRICUS BIOSCIENCES, INC.
STREET 2: 11975 EL CAMINO REAL, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
wf-form4_148374902071939.xml
FORM 4
X0306
4
2017-01-05
0
0001017491
APRICUS BIOSCIENCES, INC.
APRI
0001670896
Morton Neil
11975 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
0
1
0
0
SVP, Chief Business Officer
Common Stock
2017-01-05
4
A
0
75000
A
87949
D
Award of 75,000 Restricted Stock Units ("RSUs") under the Issuer's 2012 Stock Long Term Incentive Plan with half of the underlying shares vesting in the first open trading window following the Issuer's receipt of marketing approval of Vitaros in the United States by the Food and Drug Administration and the other half of the underlying shares fully vesting on November 30, 2018, subject to the Reporting Person's continued employment or service to the Issuer through such date and subject to accelerated vesting upon a change in control of the Issuer.
Not applicable.
/s/ Richard W. Pascoe by power of attorney for Neil Morton
2017-01-06